| Active Ingredient | FORMOTEROL | MOMETASONE |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MOMETASONE | FORMOTEROL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | As for budesonide/formoterol. |
| Caution | Nasopharyngitis, sinusitis, headache. |
| Dose Range |
Adults and Children 12 years and older: Two inhalations twice daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MOMETASONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Prophylaxis and treatment of allergic rhinitis |
| Caution | Headache, pharyngitis, epistaxis, cough, dysmenorrhea, nasal burning. Store spray away from light. |
| Dose Range | Adults and children 12 years and over: 2 sp ray s in each nostril once daily , increasing to 4 sp ray s once daily if needed. Decrease to one sp ray once daily as a maintenance dose. Pediatric (2-11 years): 1 sp ray into each nostril once da |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MOMETASONE |
| Therapeutic Class | ANTI-INFLAMMATORY AGENTS, TOPICAL |
| Indications | For relief of inflammatory and pruritic conditions. |
| Caution | See Betamethasone Valerate. Do not use occlusive dressing. |
| Dose Range | Use sparingly once daily. Rub in gently. See BDS supply protocols pg. 6. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |